Citation Impact
Citing Papers
SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures
2006
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
4-Hydroxy-2-Nonenal Mediates Genotoxicity and Bystander Effects Caused by Enterococcus faecalis–Infected Macrophages
2011
Bioactive Natural Products from Papua New Guinea Marine Sponges
2012
Molecular Chaperone-like Properties of an Unfolded Protein, αs-Casein
1999
Industrial natural product chemistry for drug discovery and development
2013
Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin
2007
Adverse Health Effects of Marijuana Use
2014 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The odyssey of marine pharmaceuticals: a current pipeline perspective
2010
Natural products: A continuing source of novel drug leads
2013 Standout
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives
2004 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Marine natural products
1990 Standout
Drug discovery from natural sources
2006
How Do Microtubule-Targeted Drugs Work? An Overview
2007
Drug development from marine natural products
2008 Standout
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
2014
Why are ?natively unfolded? proteins unstructured under physiologic conditions?
2000 Standout
The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas
2007
ER export: public transportation by the COPII coach
2001 StandoutNobel
Comparison of the Activities of the Truncated Halichondrin B Analog NSC 707389 (E7389) with Those of the Parent Compound and a Proposed Binding Site on Tubulin
2006
Marine pharmacology in 2001–2: antitumour and cytotoxic compounds
2004
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole
2012
Miswiring the brain: 9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway
2014
From the Sea to Anticancer Therapy
2011
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011
Malignant Gliomas in Adults
2008 Standout
The Local Electrostatic Environment Determines Cysteine Reactivity of Tubulin
2002
Genomic insights into head and neck cancer
2016
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
2011
How were new medicines discovered?
2011 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Diverse Engineered Heme Proteins Enable Stereodivergent Cyclopropanation of Unactivated Alkenes
2018 StandoutNobel
Natively unfolded proteins: A point where biology waits for physics
2002 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Interactions of Halichondrin B and Eribulin with Tubulin
2011
Drug discovery from medicinal plants
2005 Standout
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
The molecular landscape of head and neck cancer
2018 Standout
Enhancement of metabolites productivity of Penicillium pinophilum FKI-5653, by co-culture with Trichoderma harzianum FKI-5655
2011 StandoutNobel
Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
2011
Allicin inhibits cell polarization, migration and division via its direct effect on microtubules
2007
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Ruthenium‐Catalyzed C7 Amidation of Indoline CH Bonds with Sulfonyl Azides
2014
Natural products in drug discovery
2008 Standout
Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology
2012
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Phenotypic screening in cancer drug discovery — past, present and future
2014
Protein S-nitrosylation: purview and parameters
2005 Standout
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Iridium(iii )-catalyzed regioselective C7-sulfonamidation of indoles
2016
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program
2013
Antitubulin agents for the treatment of cancer – a medicinal chemistry update
2006
Structural Insights into Microtubule Function
2000
Structural Insights into Microtubule Function
2001
Design of nickel chelates of tetradentate N-heterocyclic carbenes with subdued cytotoxicity
2009
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase
2008
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
2014
Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer
2012
Stathmin 1: a novel therapeutic target for anticancer activity
2008
Organometallic Anticancer Compounds
2010 Standout
A Molecular View of Kinetochore Assembly and Function
2017
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Deep Eutectic Solvents as a New Generation of Chemical Chaperones
2018
Anticancer and Antimicrobial Metallopharmaceutical Agents Based on Palladium, Gold, and Silver N-Heterocyclic Carbene Complexes
2007
Allicin: Chemistry and Biological Properties
2014 Standout
A Direct Access to 7-Aminoindoles via Iridium-Catalyzed Mild C–H Amidation of N-Pivaloylindoles with Organic Azides
2016
Heat tolerance in plants: An overview
2007 Standout
Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development
2022 StandoutNobel
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2009
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2015
Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent
2015
Deep Eutectic Solvents: A Review of Fundamentals and Applications
2020 Standout
Dinuclear Copper(I) Complexes Containing Cyclodiphosphazane Derivatives and Pyridyl Ligands: Synthesis, Structural Studies, and Antiproliferative Activity toward Human Cervical and Breast Cancer Cells
2010
Direct and Site‐Selective Palladium‐Catalyzed C‐7 Acylation of Indolines with Aldehydes
2015
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Pharmacological Developments Obtained from Marine Natural Products and Current Pipeline Perspective
2011
Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability
2009
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
The exciton model in molecular spectroscopy
1965 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
LEA proteins prevent protein aggregation due to water stress
2005
Photoinduced electron transfer processes in fullerene–organic chromophore systems
2011
Transition Metal-Catalyzed C–H Amination: Scope, Mechanism, and Applications
2017 Standout
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Eribulin mesylate
2011
Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin
2014
Diverse functional manifestations of intrinsic structural disorder in molecular chaperones
2012
Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play”
2016
Works of Tapas Manna being referenced
Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin
2009
Dynein light intermediate chain 1 is required for progress through the spindle assembly checkpoint
2009
Sulfhydryls of tubulin
2000
Role of the carboxy‐termini of tubulin on its chaperone‐like activity
2001
Chaperone-like Activity of Tubulin
1998
TACC3 Protein Regulates Microtubule Nucleation by Affecting γ-Tubulin Ring Complexes
2014
MAP2 prevents protein aggregation and facilitates reactivation of unfolded enzymes
2004
Chaperone-like Activity of Tubulin
2001
Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro
2005
Conformational Properties of α-Tubulin Tail Peptide: Implications for Tail−Body Interaction
2001
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
2005
Antimitotic Sulfonamides Inhibit Microtubule Assembly Dynamics and Cancer Cell Proliferation
2006
Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate
2007
Antimitotic Sulfonamides Inhibit Microtubule Assembly Dynamics and Cancer Cell Proliferation
2006
Stathmin Family Protein SCG10 Differentially Regulates the Plus and Minus End Dynamics of Microtubules at Steady State in Vitro: Implications for Its Role in Neurite Outgrowth
2007
AB INITIO AND DFT THEORETICAL INVESTIGATIONS ON NOVEL PORPHYRIN–FULLERENE SUPRAMOLECULAR DYADS FOR PHOTOVOLTAIC DEVICES
2008